Molecular pathways of major depressive disorder converge on the synapse | Molecular Psychiatry – Nature.com

Hasin DS, Sarvet AL, Meyers JL, Saha TD, Ruan WJ, Stohl M, et al. Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States. JAMA Psychiatry. 2018;75:33646.

PubMed PubMed Central Article Google Scholar

Malhi GS, Mann JJ. Depression. Lancet. 2018;392:2299312.

PubMed Article Google Scholar

Santomauro DF, Mantilla Herrera AM, Shadid J, Zheng P, Ashbaugh C, Pigott DM, et al. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet. 2021;398:170012.

Article Google Scholar

American Psychiatric Association DS, Association AP, Others. Diagnostic and statistical manual of mental disorders: DSM-5, Vol. 5. Washington, DC: American Psychiatric Association; 2013.

Book Google Scholar

Caldiroli A, Capuzzi E, Tagliabue I, Capellazzi M, Marcatili M, Mucci F, et al. Augmentative pharmacological strategies in treatment-resistant major depression: a comprehensive review. Int J Mol Sci. 2021;22:13070.

CAS PubMed PubMed Central Article Google Scholar

Zhuo C, Li G, Lin X, Jiang D, Xu Y, Tian H, et al. The rise and fall of MRI studies in major depressive disorder. Transl Psychiatry. 2019;9:335.

PubMed PubMed Central Article Google Scholar

Nolan M, Roman E, Nasa A, Levins KJ, OHanlon E, OKeane V, et al. Hippocampal and amygdalar volume changes in major depressive disorder: a targeted review and focus on stress. Chronic Stress. 2020;4:2470547020944553.

PubMed PubMed Central Article Google Scholar

Hellewell SC, Welton T, Maller JJ, Lyon M, Korgaonkar MS, Koslow SH, et al. Profound and reproducible patterns of reduced regional gray matter characterize major depressive disorder. Transl Psychiatry. 2019;9:176.

PubMed PubMed Central Article Google Scholar

Schmaal L, Pozzi E, Ho TC, van Velzen LS, Veer IM, Opel N, et al. ENIGMA MDD: seven years of global neuroimaging studies of major depression through worldwide data sharing. Transl Psychiatry. 2020;10:172.

PubMed PubMed Central Article Google Scholar

Stockmeier CA, Rajkowska G. Cellular abnormalities in depression: evidence from postmortem brain tissue. Dialogues Clin Neurosci. 2004;6:18597.

PubMed PubMed Central Article Google Scholar

Duric V, Banasr M, Stockmeier CA, Simen AA, Newton SS, Overholser JC, et al. Altered expression of synapse and glutamate related genes in post-mortem hippocampus of depressed subjects. Int J Neuropsychopharmacol. 2013;16:6982.

CAS PubMed Article Google Scholar

Li J, Seidlitz J, Suckling J, Fan F, Ji GJ, Meng Y, et al. Cortical structural differences in major depressive disorder correlate with cell type-specific transcriptional signatures. Nat Commun. 2021;12:1647.

CAS PubMed PubMed Central Article Google Scholar

Prentner R. Consciousness: a molecular perspective. Philosophies. 2017;2:26.

Article Google Scholar

Sohn E. Decoding the neuroscience of consciousness. Nature. 2019;571:S25.

CAS PubMed Article Google Scholar

Shadrina M, Bondarenko EA, Slominsky PA. Genetics factors in major depression disease. Front Psychiatry. 2018;9:334.

PubMed PubMed Central Article Google Scholar

Major Depressive Disorder Working Group of the Psychiatric GWAS Consortium, Ripke S, Wray NR, Lewis CM, Hamilton SP, Weissman MM, et al. A mega-analysis of genome-wide association studies for major depressive disorder. Mol Psychiatry. 2013;18:497511.

Article Google Scholar

Viktorin A, Meltzer-Brody S, Kuja-Halkola R, Sullivan PF, Landn M, Lichtenstein P, et al. Heritability of perinatal depression and genetic overlap with nonperinatal depression. Am J Psychiatry. 2016;173:15865.

PubMed Article Google Scholar

Levey DF, Stein MB, Wendt FR, Pathak GA, Zhou H, Aslan M, et al. Bi-ancestral depression GWAS in the Million Veteran Program and meta-analysis in >1.2 million individuals highlight new therapeutic directions. Nat Neurosci. 2021;24:95463.

CAS PubMed PubMed Central Article Google Scholar

Noh K, Park JC, Han JS, Lee SJ. From bound cells comes a sound mind: the role of neuronal growth regulator 1 in psychiatric disorders. Exp Neurobiol. 2020;29:110.

PubMed PubMed Central Article Google Scholar

Dennis EL, Jahanshad N, Braskie MN, Warstadt NM, Hibar DP, Kohannim O, et al. Obesity gene NEGR1 associated with white matter integrity in healthy young adults. Neuroimage. 2014;102:54857.

CAS PubMed Article Google Scholar

Amare AT, Schubert KO, Tekola-Ayele F, Hsu YH, Sangkuhl K, Jenkins G, et al. The association of obesity and coronary artery disease genes with response to SSRIs treatment in major depression. J Neural Transm. 2019;126:3545.

CAS PubMed Article Google Scholar

Zhang YQ, Lin WP, Huang LP, Zhao B, Zhang CC, Yin DM. Dopamine D2 receptor regulates cortical synaptic pruning in rodents. Nat Commun. 2021;12:6444.

CAS PubMed PubMed Central Article Google Scholar

Wagnon JL, Briese M, Sun W, Mahaffey CL, Curk T, Rot G, et al. CELF4 regulates translation and local abundance of a vast set of mRNAs, including genes associated with regulation of synaptic function. PLoS Genet. 2012;8:e1003067.

CAS PubMed PubMed Central Article Google Scholar

Shen Y, Zhang C, Xiao K, Liu D, Xie G. CELF4 regulates spine formation and depression-like behaviors of mice. Biochem Biophys Res Commun. 2022;605:3944.

CAS PubMed Article Google Scholar

Starnawska A, Tan Q, Soerensen M, McGue M, Mors O, Brglum AD, et al. Epigenome-wide association study of depression symptomatology in elderly monozygotic twins. Transl Psychiatry. 2019;9:214.

CAS PubMed PubMed Central Article Google Scholar

Chan RF, Turecki G, Shabalin AA, Guintivano J, Zhao M, Xie LY, et al. Cell typespecific methylome-wide association studies implicate neurotrophin and innate immune signaling in major depressive disorder. Biol Psychiatry. 2020;87:43142.

CAS PubMed Article Google Scholar

Roberson-Nay R, Lapato DM, Wolen AR, Lancaster EE, Webb BT, Verhulst B, et al. An epigenome-wide association study of early-onset major depression in monozygotic twins. Transl Psychiatry. 2020;10:301.

CAS PubMed PubMed Central Article Google Scholar

Litke C, Bading H, Mauceri D. Histone deacetylase 4 shapes neuronal morphology via a mechanism involving regulation of expression of vascular endothelial growth factor D. J Biol Chem. 2018;293:8196207.

CAS PubMed PubMed Central Article Google Scholar

Kim MS, Akhtar MW, Adachi M, Mahgoub M, Bassel-Duby R, Kavalali ET, et al. An essential role for histone deacetylase 4 in synaptic plasticity and memory formation. J Neurosci. 2012;32:1087986.

CAS PubMed PubMed Central Article Google Scholar

Shi Y, Wang Q, Song R, Kong Y, Zhang Z. Non-coding RNAs in depression: promising diagnostic and therapeutic biomarkers. EBioMedicine. 2021;71:103569.

CAS PubMed PubMed Central Article Google Scholar

Dwivedi Y. MicroRNAs in depression and suicide: recent insights and future perspectives. J Affect Disord. 2018;240:14654.

CAS PubMed PubMed Central Article Google Scholar

Deussing JM, Jakovcevski M. Histone modifications in major depressive disorder and related rodent models. Adv Exp Med Biol. 2017;978:16983.

CAS PubMed Article Google Scholar

Homorogan C, Nitusca D, Seclaman E, Enatescu V, Marian C. Uncovering the roles of microRNAs in major depressive disorder: from candidate diagnostic biomarkers to treatment response indicators. Life. 2021;11:1073.

CAS PubMed PubMed Central Article Google Scholar

Xu N, Li AD, Ji LL, Ye Y, Wang ZY, Tong L. miR-132 regulates the expression of synaptic proteins in APP/PS1 transgenic mice through C1q. Eur J Histochem. 2019;63:3008.

PubMed Central Article Google Scholar

Scott HL, Tamagnini F, Narduzzo KE, Howarth JL, Lee YB, Wong LF, et al. MicroRNA-132 regulates recognition memory and synaptic plasticity in the perirhinal cortex. Eur J Neurosci. 2012;36:29418.

PubMed PubMed Central Article Google Scholar

Hamon M, Blier P. Monoamine neurocircuitry in depression and strategies for new treatments. Prog Neuropsychopharmacol Biol Psychiatry. 2013;45:5463.

CAS PubMed Article Google Scholar

Kaltenboeck A, Harmer C. The neuroscience of depressive disorders: a brief review of the past and some considerations about the future. Brain Neurosci Adv. 2018;2:2398212818799269.

PubMed PubMed Central Article Google Scholar

Pan JX, Xia JJ, Deng FL, Liang WW, Wu J, Yin BM, et al. Diagnosis of major depressive disorder based on changes in multiple plasma neurotransmitters: a targeted metabolomics study. Transl Psychiatry. 2018;8:130.

PubMed PubMed Central Article Google Scholar

Fogaa MV, Duman RS. Cortical GABAergic dysfunction in stress and depression: new insights for therapeutic interventions. Front Cell Neurosci. 2019;13:87.

PubMed PubMed Central Article Google Scholar

Luscher B, Shen Q, Sahir N. The GABAergic deficit hypothesis of major depressive disorder. Mol Psychiatry. 2011;16:383406.

CAS PubMed Article Google Scholar

Duman RS, Sanacora G, Krystal JH. Altered connectivity in depression: GABA and glutamate neurotransmitter deficits and reversal by novel treatments. Neuron. 2019;102:7590.

CAS PubMed PubMed Central Article Google Scholar

Shin C, Kim YK. Ketamine in major depressive disorder: mechanisms and future perspectives. Psychiatry Investig. 2020;17:18192.

CAS PubMed PubMed Central Article Google Scholar

Zanos P, Moaddel R, Morris PJ, Georgiou P, Fischell J, Elmer GI, et al. NMDAR inhibition-independent antidepressant actions of ketamine metabolites. Nature. 2016;533:4816.

CAS PubMed PubMed Central Article Google Scholar

Edinoff AN, Odisho AS, Lewis K, Kaskas A, Hunt G, Cornett EM, et al. Brexanolone, a GABAA modulator, in the treatment of postpartum depression in adults: a comprehensive review. Front Psychiatry. 2021;12:699740.

PubMed PubMed Central Article Google Scholar

Prez de la Mora M, Borroto-Escuela DO, Crespo-Ramrez M, Rejn-Orantes JDC, Palacios-Lagunas DA, Martnez-Mata MK, et al. Dysfunctional heteroreceptor complexes as novel targets for the treatment of major depressive and anxiety disorders. Cells. 2022;11:1826.

PubMed PubMed Central Article Google Scholar

Reeves KC, Shah N, Muoz B, Atwood BK. Opioid receptor-mediated regulation of neurotransmission in the brain. Front Mol Neurosci. 2022;15:919773.

CAS PubMed PubMed Central Article Google Scholar

Puryear CB, Brooks J, Tan L, Smith K, Li Y, Cunningham J, et al. Opioid receptor modulation of neural circuits in depression: what can be learned from preclinical data? Neurosci Biobehav Rev. 2020;108:65878.

PubMed Article Google Scholar

Pecia M, Karp JF, Mathew S, Todtenkopf MS, Ehrich EW, Zubieta JK. Endogenous opioid system dysregulation in depression: implications for new therapeutic approaches. Mol Psychiatry. 2019;24:57687.

PubMed Article Google Scholar

Browne CA, Lucki I. Targeting opioid dysregulation in depression for the development of novel therapeutics. Pharm Ther. 2019;201:5176.

CAS Article Google Scholar

Hsu DT, Sanford BJ, Meyers KK, Love TM, Hazlett KE, Walker SJ, et al. It still hurts: altered endogenous opioid activity in the brain during social rejection and acceptance in major depressive disorder. Mol Psychiatry. 2015;20:193200.

CAS PubMed PubMed Central Article Google Scholar

Continued here:
Molecular pathways of major depressive disorder converge on the synapse | Molecular Psychiatry - Nature.com